Dr. Xin-Xing Tan Wins an Award from the American Society for Microbiology
CytoGenix, Inc. (CYGX.OB) announced today that Dr. Xin-Xing Tan will receive an award presented by the Program Committee of the 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) organized by the American Society of Microbiology (ASM) at the upcoming ICAAC annual meeting. This monetary award acknowledges the quality and level of innovation demonstrated in the work entitled Novel DNA Aptamers against Staphylococcus aureus Identified by Whole-Bacterium SELEX. Dr. Tan’s paper will be presented in the section on Therapy and Prevention of Microbial Diseases at the ICAAC meeting September 17-20, 2007 in Chicago, Illinois.
The ICAAC is the world’s premier meeting on infectious diseases and antimicrobial agents, with nearly 100 countries represented, and more than half of the expected 12,000 attendees traveling from outside of the United States. The ICAAC provides a unique global networking and educational opportunity. This year’s conference will attract more than 12,000 participants including physicians, clinical microbiologists, researchers, pharmacists, and other healthcare professionals from around the world.
This award to Dr Tan represents recognition of CytoGenix technology and the Company’s efforts to develop effective treatment for drug resistant bacteria.
CytoGenix, Inc. is a Houston-based biopharmaceutical company that develops and markets innovative products and services based on its proprietary synDNA™ production and ssDNA expression technology. The company has developed a breakthrough synthetic process for large-scale production of biologically active DNA that can be made faster and cleaner than production using traditional fermentation methods and has developed a novel expression vector that enables production of therapeutic DNA inside the cell. CytoGenix currently holds 11 granted patents and about 49 international or US pending patent applications claiming methods and materials in connection with these platform technologies.
This news content was configured by WebWire editorial staff. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.